12/12/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
5:01 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:20 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
07/30/2024
5:00 AM | Alzamend Neuro (Filer)
| Form NT 10-K | |
07/12/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ALZN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. |
07/10/2024
7:52 AM | Alzamend Neuro (Filer)
| Form 424B3 | |
07/09/2024
11:15 PM | Alzamend Neuro (Filer)
| Form EFFECT | |
07/08/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:31 PM | Alzamend Neuro (Filer)
| Form S-1/A | |
06/26/2024
3:46 PM | Alzamend Neuro (Filer)
| Form S-1/A | |
06/11/2024
3:30 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
06/03/2024
3:30 PM | Alzamend Neuro (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/22/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
3:30 PM | Alzamend Neuro (Issuer)
McGrath Lynne Fahey (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
05/10/2024
4:06 PM | Alzamend Neuro (Filer)
| Form PRE 14A | |
05/10/2024
5:30 AM | Alzamend Neuro (Filer)
| Form 424B5 | |
05/09/2024
3:20 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
3:31 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
04/23/2024
7:00 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:00 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:27 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
3:30 PM | Alzamend Neuro (Filer)
| Form NT 10-Q | |
03/13/2024
3:30 PM | Alzamend Neuro (Filer)
| Form PRE 14A | |
03/07/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
